NanoViricides, Inc.
NNVC · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $24 | $23 | $19 | $21 |
| - Cash | $1,125,711 | $2 | $3 | $4 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$1,125,687 | $22 | $16 | $17 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.1 | -0.13 | -0.14 | -0.14 |
| % Growth | 23.1% | 7.1% | 0% | – |
| Operating Cash Flow | -$2 | -$2 | -$2 | -$2 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$2 | -$2 | -$2 | -$2 |